Clinical trials sponsored by Guangdong Provincial People's Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Guangdong Provincial People's Hospital

• A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
  NCT04212455 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer
  NCT07352930 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients
  NCT06811870 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: Female · 2 locations
• A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
  NCT05188885 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
  NCT06758544 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
  NCT07136792 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 24 locations
• A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure
  NCT07047547 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
  NCT04381143 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 139 locations
• Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC
  NCT06771960 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
  NCT07441382 · Phase: Not applicable (e.g. observational or device study) · Ages: 75 Years and older · Sex: All (male and female) · 1 location
• Community Exercise Treating Effect on Cardiopulmonary Disease Patients
  NCT07154355 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Correlation of Timing of Pegfilgrastim Administration and PIBP.
  NCT05841186 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC
  NCT07016126 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• EACH-ADHF: Early Comprehensive Rehabilitation in Patients With ADHF
  NCT06161987 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
  NCT07025590 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
  NCT07098351 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension
  NCT07604805 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis
  NCT05189496 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• MRD Monitoring in Lung Cancer After Resection
  NCT04976296 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
  NCT06676631 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer
  NCT06734182 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
  NCT05800340 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Organoid-based Functional Precision Therapy for Advanced Breast Cancer
  NCT06102824 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC
  NCT06533384 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients
  NCT06215326 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06911606 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
  NCT06244264 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial
  NCT07514611 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Guangdong Provincial People's Hospital recruiting for?

Guangdong Provincial People's Hospital is the lead sponsor of 28 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.